85 related articles for article (PubMed ID: 4283337)
21. Cutaneous manifestations of systemic disease.
Cahill J; Sinclair R
Aust Fam Physician; 2005 May; 34(5):335-40. PubMed ID: 15887934
[TBL] [Abstract][Full Text] [Related]
22. Iatrogenic skin disease.
Verbov J
Br J Clin Pract; 1973 Aug; 27(8):510-4. PubMed ID: 4271486
[No Abstract] [Full Text] [Related]
23. [Dermal changes in rheumatic diseases].
Kreysel HW; Kimmig J
Internist (Berl); 1974 Jun; 15(6):304-11. PubMed ID: 4603062
[No Abstract] [Full Text] [Related]
24. [Drug eruptions caused by beta-blockers].
Bonnetblanc JM
Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136
[TBL] [Abstract][Full Text] [Related]
25. Systems of life No 65. Systems and signs: the skin - 2.
Roberts A
Nurs Times; 1980 May; 76(18):suppl 1-4. PubMed ID: 6900285
[No Abstract] [Full Text] [Related]
26. [Nonmetastatic cutaneous manifestations of visceral tumors].
Valdés EF; Gozzi HD
Rev Clin Esp; 1972 Jan; 124(2):163-6. PubMed ID: 4552523
[No Abstract] [Full Text] [Related]
27. Skin mosaic.
Br Med J; 1966 Apr; 1(5494):998-9. PubMed ID: 5909857
[No Abstract] [Full Text] [Related]
28. Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent.
Jaber SH; Cowen EW; Haworth LR; Booher SL; Berman DM; Rosenberg SA; Hwang ST
Arch Dermatol; 2006 Feb; 142(2):166-72. PubMed ID: 16490844
[TBL] [Abstract][Full Text] [Related]
29. [On the use of cytostatic drugs in dermatology].
Knoth W
Ther Umsch; 1969 Feb; 26(2):89-93. PubMed ID: 5771454
[No Abstract] [Full Text] [Related]
30. [Polygenic inheritance of familial malignant melanoma].
Happle R; Traupe H
Hautarzt; 1982 Feb; 33(2):106-11. PubMed ID: 7042646
[TBL] [Abstract][Full Text] [Related]
31. Intertriginous and follicular eruption to anticytotoxic T-lymphocyte antigen 4 monoclonal antibody.
Lim JL; Dahiya M; Burgin S
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S60-1. PubMed ID: 18625394
[No Abstract] [Full Text] [Related]
32. Xeroderma pigmentosum complementation group G in association with malignant melanoma.
Yoneda K; Moriue J; Matsuoka Y; Moriwaki S; Moriue T; Nakai K; Yokoi I; Nibu N; Demitsu T; Kubota Y
Eur J Dermatol; 2007; 17(6):540-1. PubMed ID: 17951140
[No Abstract] [Full Text] [Related]
33. Skin manifestations of SLE.
Gilliam JN; Sontheimer RD
Clin Rheum Dis; 1982 Apr; 8(1):207-18. PubMed ID: 6749395
[No Abstract] [Full Text] [Related]
34. A case of melanoma in xeroderma pigmentosum.
Rao TN; Bhagyalaxmi A; Ahmed K; Mohana Rao TS; Venkatachalam K
Indian J Pathol Microbiol; 2009; 52(4):524-6. PubMed ID: 19805962
[TBL] [Abstract][Full Text] [Related]
35. [Skin reactivity in patients with chronic diseases of digestive organs].
Burykina GN
Vestn Dermatol Venerol; 1966 Nov; 40(11):10-5. PubMed ID: 6002984
[No Abstract] [Full Text] [Related]
36. Ultraviolet carcinogenesis.
Epstein JH
Photophysiology; 1970; 5():235-73. PubMed ID: 4950133
[No Abstract] [Full Text] [Related]
37. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
38. [The skin as a mirror].
Beritić T
Lijec Vjesn; 1966 Aug; 88(8):979-81. PubMed ID: 4862308
[No Abstract] [Full Text] [Related]
39. Skin signs of internal disease.
Abdul Ghaffar S; Clements SE; Yell J
Practitioner; 2005 Jun; 249(1671):434, 436, 438 passim. PubMed ID: 15966277
[No Abstract] [Full Text] [Related]
40. Human immunodeficiency virus disease in the era of HAART: a reevaluation of the mucocutaneous manifestations.
Johnson RA
Curr Clin Top Infect Dis; 1999; 19():252-86. PubMed ID: 10472490
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
